In the BioHarmony Drug Report Database

"Preview" Icon

Pramipexole

Mirapex, Mirapex Er, Mirapexin, Sifrol (pramipexole) is a small molecule pharmaceutical. Pramipexole was first approved as Mirapex on 1997-07-01. It is used to treat depressive disorder and parkinson disease in the USA. It has been approved in Europe to treat parkinson disease and restless legs syndrome. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Mirapex’s patents are valid until 2029-09-08 (FDA).

 

Trade Name

 

Mirapexin, Sifrol
 

Common Name

 

pramipexole
 

ChEMBL ID

 

CHEMBL301265
 

Indication

 

depressive disorder, parkinson disease, restless legs syndrome
 

Drug Class

 

Image (chem structure or protein)

Pramipexole structure rendering